Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing research and development (r&d) activities at academic institutes and medical organizations, increasing prevalence of infectious diseases, and increasing demand for advanced diagnostic measures.
The nucleic acid amplification market is segmented as below:
By Technique
- Target amplification
- Probe amplification
- Signal amplification
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the nucleic acid amplification market covers the following areas:
- Nucleic acid amplification market sizing
- Nucleic acid amplification market forecast
- Nucleic acid amplification market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The companies presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
The following companies are recognized as the key players in the global nucleic acid amplification market: Abbott Laboratories, Becton Dickinson and Co., bioMerieux SA, Ustar Biotechnologies Hangzhou Ltd., Danaher Corp., Eiken Chemical Co. Ltd., F. Hoffmann La Roche Ltd., Grifols SA, Hologic Inc., Illumina Inc., LGC Science Group Holdings Ltd., Meridian Bioscience Inc., New England Biolabs Inc., Novartis AG, OptiGene Ltd., Promega Corp., Quidelortho Corp., Siemens AG, Tecan Trading AG, and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing investment in development of new biotechnological techniques."
According to the report, one of the major drivers for this market is the increasing research and development (r&d) activities at academic institutes and medical organizations.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Becton Dickinson and Co.
- bioMerieux SA
- Ustar Biotechnologies Hangzhou Ltd.
- Danaher Corp.
- Eiken Chemical Co. Ltd.
- F. Hoffmann La Roche Ltd.
- Grifols SA
- Hologic Inc.
- Illumina Inc.
- LGC Science Group Holdings Ltd.
- Meridian Bioscience Inc.
- New England Biolabs Inc.
- Novartis AG
- OptiGene Ltd.
- Promega Corp.
- Quidelortho Corp.
- Siemens AG
- Tecan Trading AG
- Thermo Fisher Scientific Inc.